Kindeva Drug Delivery

02 NOVEMBER 2026 – Kindeva, a global contract development and manufacturing organization (CDMO) specializing in complex drug and combination product delivery, today announced the appointment of Daniel Couto as Executive Vice President, Inhalation & Specialty Drug Delivery. Joining Kindeva’s executive leadership team, Couto will have executive responsibility for the strategy, growth and performance of Kindeva’s…

15 Oct 2026:  Kindeva’s global health security division, Meridian Medical Technologies, LLC, has been awarded a $226 million contract to provide life-saving Antidote Treatment Nerve Agent Autoinjectors (ATNAA) for Defense Logistics Agency customers. With the potential of delivering over 3 million units from Kindeva’s autoinjector assembly center, the contract is set to support the U.S….

Kindeva, a global drug delivery Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Brok Weichbrodt as Chief Transformation Officer to strengthen operational excellence, scale execution, and accelerate growth as the company enters the next phase of its value creation plan. With over 20 years of experience in the pharmaceutical and biotech sector,…

4 June 2024 — Loughborough, UK; Minnesota, US; and Missouri, US — Leading global drug-device combination product CDMO Kindeva Drug Delivery today announced the expansion of their Loughborough, UK, facilities at the Charnwood Campus Science Innovation and Technology Park. This strategic move by Kindeva supports the growth of green propellant commercialisation and secures a dedicated…

6 May 2024 — Minnesota, US, and Missouri, US — Kindeva Drug Delivery, a global leader in drug-device combination products, today announced its investment in a second manufacturing line for the production of pressurised metered-dose inhaler (pMDI) products containing low-GWP (Global Warming Potential) propellants in its Loughborough, UK, facility. This new line will be capable of…

18 March 2024 — Minnesota, US, and Missouri, US — Kindeva Drug Delivery, a global leader in drug-device combination products, today welcomes Jennifer Riter as vice president of Analytical Services to head up the recently announced analytical services global business unit. Riter comes to Kindeva from West Pharmaceutical where she spent the past 27 years in…

31 January 2024 — Minnesota, US and Missouri, US — Kindeva Drug Delivery, a global leader in drug-device combination products, announced the expansion of its analytical services capabilities — launching a new global business unit offering integrated and stand-alone analytical support to the wider pharmaceutical, biopharmaceutical and medical device sector. For more than half a…